187 related articles for article (PubMed ID: 37350585)
1. Temporary implantable nitinol device for benign prostatic hyperplasia-related lower urinary tract symptoms: over 48-month results.
Amparore D; De Cillis S; Schulman C; Kadner G; Fiori C; Porpiglia F
Minerva Urol Nephrol; 2023 Dec; 75(6):743-751. PubMed ID: 37350585
[TBL] [Abstract][Full Text] [Related]
2. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
[TBL] [Abstract][Full Text] [Related]
3. Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study.
Kadner G; Valerio M; Giannakis I; Manit A; Lumen N; Ho BSH; Alonso S; Schulman C; Barber N; Amparore D; Porpiglia F
World J Urol; 2020 Dec; 38(12):3235-3244. PubMed ID: 32124019
[TBL] [Abstract][Full Text] [Related]
4. Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.
De Nunzio C; Cantiello F; Fiori C; Crocerossa F; Tognoni P; Amparore D; Baldassarri V; Elbers JR; Sancha FG; Porpiglia F
World J Urol; 2021 Jun; 39(6):2037-2042. PubMed ID: 32851439
[TBL] [Abstract][Full Text] [Related]
5. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
[TBL] [Abstract][Full Text] [Related]
6. 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction.
Amparore D; Fiori C; Valerio M; Schulman C; Giannakis I; De Cillis S; Kadner G; Porpiglia F
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):349-357. PubMed ID: 33005003
[TBL] [Abstract][Full Text] [Related]
7. 3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction.
Porpiglia F; Fiori C; Bertolo R; Giordano A; Checcucci E; Garrou D; Cattaneo G; De Luca S; Amparore D
BJU Int; 2018 Jul; 122(1):106-112. PubMed ID: 29359881
[TBL] [Abstract][Full Text] [Related]
8. The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial.
Chughtai B; Elterman D; Shore N; Gittleman M; Motola J; Pike S; Hermann C; Terrens W; Kohan A; Gonzalez RR; Katz A; Schiff J; Goldfischer E; Grunberger I; Tu LM; Alshak MN; Kaminetzky J
Urology; 2021 Jul; 153():270-276. PubMed ID: 33373708
[TBL] [Abstract][Full Text] [Related]
9. Operative profile, safety and functional outcomes after GreenLight laser prostate surgery: results from a 12 months follow-up multicenter Italian cohort analyses.
Reale G; Marchioni M; Altieri V; Greco F; De Nunzio C; Destefanis P; Ricciardulli S; Bergamaschi F; Fasolis G; Varvello F; Voce S; Palmieri F; Divan C; Malossini G; Oriti R; Tuccio A; Ruggera L; Tubaro A; Delicato G; Laganà A; Dadone C; De Rienzo G; Ditonno A; Frattini A; Pucci L; Carrino M; Montefiore F; Germani S; Miano R; Schips L; Rabito S; Ferrari G; Cindolo L
Minerva Urol Nefrol; 2020 Oct; 72(5):622-628. PubMed ID: 32284526
[TBL] [Abstract][Full Text] [Related]
10. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
[TBL] [Abstract][Full Text] [Related]
11. First-in-man Safety and Efficacy of the ClearRing Implant for the Treatment of Benign Prostatic Hyperplasia.
Vjaters E; Nitsan D; Mullerad M; Engelstein D; Leibovitch I; Feld Y
Eur Urol Focus; 2020 Jan; 6(1):131-136. PubMed ID: 30293945
[TBL] [Abstract][Full Text] [Related]
12. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
15. Temporarily implanted nitinol device versus prostatic urethral lift for minimally invasive surgical treatment of benign prostatic hyperplasia with lower urinary tract symptoms: a matching-adjusted indirect comparison.
Kernen KM; Omar S; Goodnight B; Skodny P; Bruce S; Yu TM
Can J Urol; 2023 Oct; 30(5):11676-11685. PubMed ID: 37838995
[TBL] [Abstract][Full Text] [Related]
16. Rezum water vapor therapy for patients with mild, moderate, or severe lower urinary tract symptoms: A retrospective study in a multiethnic population.
Babar M; Loloi J; Tang K; Singh S; Ines M; Patel RD; Iqbal N; Ciatto M
Prostate; 2023 May; 83(7):713-721. PubMed ID: 36879380
[TBL] [Abstract][Full Text] [Related]
17. Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.
Gilling PJ; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Kaufman RP; Badlani G; Plante M; Desai M; Doumanian L; Te AE; Roehrborn CG
Can J Urol; 2022 Feb; 29(1):10960-10968. PubMed ID: 35150215
[TBL] [Abstract][Full Text] [Related]
18. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
19. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
[TBL] [Abstract][Full Text] [Related]
20. Emerging minimally invasive transurethral treatments for benign prostatic hyperplasia: a systematic review with meta-analysis of functional outcomes and description of complications.
Manfredi C; Arcaniolo D; Spatafora P; Crocerossa F; Fusco F; Verze P; Fiori C; Damiano R; Cindolo L; DE Sio M; Otero JR
Minerva Urol Nephrol; 2022 Aug; 74(4):389-399. PubMed ID: 34308611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
